GovernmentExecutive.com

Sen. Chuck Grassley, R-Iowa, is on another federal agency's case. This time, he's hounding the FDA about the relationship between "nonarteritic anterior ischemic optic neuropathy and the use of drugs prescribed by physicians to treat erectile dysfunction." What's the big deal? Well, "nonarteritic anterior ischemic optic neuropathy" is, in layman's terms, blindness. The FDA says it's posted info on its Web site about the link between ED drugs and vision loss. Not good enough, says Grassley. While some people may have seen that info, he told FDA officials, "there are millions more who remain in the dark." Umm, so to speak.